CHENYSEServices-Home Health Care ServicesFiscal year ends December 31
CHEMED CORP
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 31, 2026
$508.29−4.09 (-0.80%)
Close on Oct 19, 2026
- Market cap
- $6.71B
- P/E (TTM)
- 25.5
- Dividend yield
- 0.43%
Chemed statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Services-Home Health Care Services companies for comparison
Valuation
| Measure | Chemed | Industry median |
|---|---|---|
| Market Cap | $6.64B | $1.07B |
| Enterprise Value | $6.74B | $1.35B |
| PE Ratio | 25.52 | 22.36 |
| PS Ratio | 2.56 | 1.63 |
| PB Ratio | 8.00 | 3.19 |
| P/TBV Ratio | 126.51 | 4.88 |
| P/FCF Ratio | 20.54 | 19.54 |
| P/OCF Ratio | 17.04 | 14.51 |
Enterprise value
| Measure | Chemed | Industry median |
|---|---|---|
| EV / Sales | 2.60 | 1.78 |
| EV / EBITDA | 16.22 | 14.40 |
| EV / EBIT | 19.31 | 19.04 |
| EV / FCF | 20.85 | 23.16 |
Income (trailing twelve months)
| Measure | Chemed | Industry median |
|---|---|---|
| Revenue | $2.60B | $543.94M |
| Gross Profit | $859.31M | $162.51M |
| Operating Income | $349.19M | -$1.92M |
| Pretax Income | $369.16M | -$575.82K |
| Net Income | $274.99M | -$1.32M |
| EBITDA | $415.61M | -$29.24K |
| EPS (Diluted) | $19.92 | -$0.02 |
Margins
| Measure | Chemed | Industry median |
|---|---|---|
| Gross Margin | 33.1% | 32.7% |
| Operating Margin | 13.5% | -4.46% |
| Pretax Margin | 14.2% | 1.47% |
| Profit Margin | 10.6% | -3.18% |
| EBITDA Margin | 16.0% | 2.41% |
| FCF Margin | 12.5% | 3.11% |
Returns
| Measure | Chemed | Industry median |
|---|---|---|
| Return on Equity (ROE) | 27.1% | 0.49% |
| Return on Assets (ROA) | 16.7% | -3.06% |
| Return on Invested Capital (ROIC) | 27.7% | 1.25% |
| Return on Capital Employed (ROCE) | 27.7% | -2.29% |
Growth
| Measure | Chemed | Industry median |
|---|---|---|
| Revenue Growth (YoY) | 3.31% | 7.11% |
| Net Income Growth (YoY) | -5.29% | 19.6% |
| EPS Growth (YoY) | 2.36% | 25.6% |
| FCF Growth (YoY) | -11.7% | -6.04% |
| Revenue Growth (3Y CAGR) | 5.82% | 10.9% |
| Revenue Growth (5Y CAGR) | 4.00% | 13.2% |
| EPS Growth (3Y CAGR) | 3.52% | 19.8% |
| EPS Growth (5Y CAGR) | -1.20% | 9.29% |
Balance sheet
| Measure | Chemed | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $40.22M | $47.58M |
| Total Debt | $140.00M | $180.01M |
| Net Cash (Debt) | -$99.78M | $217.65K |
| Net Cash Per Share | -$7.63 | $0.01 |
| Equity (Book Value) | $830.51M | $189.59M |
| Book Value Per Share | $63.54 | $3.32 |
| Tangible Book Value | $52.51M | $1.72M |
| Working Capital | -$28.61M | $29.77M |
Financial position
| Measure | Chemed | Industry median |
|---|---|---|
| Current Ratio | 0.91 | 1.41 |
| Quick Ratio | 0.72 | 0.97 |
| Debt / Equity | 0.17 | 0.66 |
| Debt / EBITDA | 0.34 | 2.61 |
| Debt / FCF | 0.43 | 4.38 |
| Net Debt / EBITDA | 0.24 | 2.15 |
| Interest Coverage | 106.49 | -0.90 |
Cash flow (trailing twelve months)
| Measure | Chemed | Industry median |
|---|---|---|
| Operating Cash Flow | $389.95M | $1.28M |
| Capital Expenditures | -$66.49M | -$16.47M |
| Free Cash Flow | $323.47M | $23.23M |
| FCF Per Share | $24.75 | $0.37 |
Efficiency
| Measure | Chemed | Industry median |
|---|---|---|
| Asset Turnover | 1.57 | 0.83 |
| Inventory Turnover | 206.90 | 11.36 |
| Revenue Per Employee | $164.13K | $218.24K |
| Profits Per Employee | $17.39K | -$5.96K |
| Employee Count | 15,811 | 897 |
Dividends and yields
| Measure | Chemed | Industry median |
|---|---|---|
| Earnings Yield | 4.14% | -1.25% |
| FCF Yield | 4.87% | 1.43% |
| Dividend Yield | 0.43% | 0.61% |
| Buyback Yield | 9.68% | 0.25% |
| Shareholder Yield | 10.1% | 0.60% |
| Dividend Per Share | $2.20 | $1.30 |
| Dividend Growth (YoY) | 22.2% | 4.55% |
| Years of Dividend Growth | 11 | 4 |
| Payout Ratio | 12.1% | 14.1% |
| FCF Payout Ratio | 10.3% | 12.0% |
Shares
| Measure | Chemed | Industry median |
|---|---|---|
| Shares Outstanding | 13,070,000 | 58,609,450 |
| Shares Change (YoY) | -7.28% | 2.64% |
| Float | 12,906,200 | 34,865,600 |
| Shares Held by Insiders | 1.25% | 16.6% |
| Shares Held by Institutions | 103.6% | 85.9% |
Taxes
| Measure | Chemed | Industry median |
|---|---|---|
| Income Tax | $94.17M | $671.50K |
| Effective Tax Rate | 25.5% | 23.1% |
Scores
| Measure | Chemed | Industry median |
|---|---|---|
| Graham Number | $168.76 | $19.59 |
| Graham Upside | -66.8% | -47.8% |
| Altman Z-Score | 10.40 | 1.98 |
| Piotroski F-Score | 6 | 5 |
| Beneish M-Score | -2.76 | -2.71 |
Calculated by StockData from Chemed's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.